These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1736835)
41. In vitro antitumor mechanism of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++) platinum(II). Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K Anticancer Res; 1991; 11(1):151-5. PubMed ID: 2018348 [TBL] [Abstract][Full Text] [Related]
42. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats. Bartholeyns J; Koch-Weser J Cancer Res; 1981 Dec; 41(12 Pt 1):5158-61. PubMed ID: 6796266 [TBL] [Abstract][Full Text] [Related]
43. Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia. Agata N; Mase T; Izumi H; Hirano S; Iguchi H; Tone H; Takeuchi T Cancer Biochem Biophys; 1995 Nov; 15(2):95-101. PubMed ID: 8590441 [TBL] [Abstract][Full Text] [Related]
44. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Kim R; Tanabe K; Inoue H; Toge T Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo. Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561 [TBL] [Abstract][Full Text] [Related]
46. Combination vincristine and VP-16-213: evaluation of drug sequence. Jackson DV; Long TR; Rice DG; Morgan TM Cancer Biochem Biophys; 1986 Oct; 8(4):265-75. PubMed ID: 3802048 [TBL] [Abstract][Full Text] [Related]
47. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid. Morikawa K; Matsumoto T; Matsuoka Y; Koizumi K Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676 [TBL] [Abstract][Full Text] [Related]
48. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
49. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II). Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826 [TBL] [Abstract][Full Text] [Related]
50. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
51. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo]. Nishikawa K; Kusama K; Ekimoto H; Takahashi K Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858 [TBL] [Abstract][Full Text] [Related]
52. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma. Sugiyama T; Sadzuka Y Clin Cancer Res; 1999 Feb; 5(2):413-6. PubMed ID: 10037191 [TBL] [Abstract][Full Text] [Related]
53. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells. Misawa T; Kikkawa F; Maeda O; Obata NH; Higashide K; Suganuma N; Tomoda Y Jpn J Cancer Res; 1995 Jan; 86(1):88-94. PubMed ID: 7737915 [TBL] [Abstract][Full Text] [Related]
54. [Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil]. Shirasaka T; Shimamoto Y; Ohshimo H; Kimura A; Fukushima M Gan To Kagaku Ryoho; 1991 Mar; 18(3):403-9. PubMed ID: 2003740 [TBL] [Abstract][Full Text] [Related]
55. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
56. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats. Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857 [TBL] [Abstract][Full Text] [Related]
57. [Flow cytometric analysis of the effect of DWA2114R on the cell cycle traverse of RPMI 8402 cells--comparison with CDDP]. Takamoto S; Souma R Gan To Kagaku Ryoho; 1992 Apr; 19(4):469-76. PubMed ID: 1558396 [TBL] [Abstract][Full Text] [Related]
58. Potentiation of antitumor activity of bleomycin towards solid tumors in mice by Bacillus thuringiensis subsp. israelensis toxin. Yokoyama Y; Ohmori I; Kohda K; Kawazoe Y Anticancer Res; 1991; 11(4):1625-8. PubMed ID: 1720939 [TBL] [Abstract][Full Text] [Related]
59. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment. Sadzuka Y; Hatakeyama H; Sonobe T Int J Pharm; 2010 Jan; 383(1-2):186-91. PubMed ID: 19732815 [TBL] [Abstract][Full Text] [Related]
60. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]